This webinar discusses how real-time monitoring of pH, cell density, and dissolved oxygen concentration with optical sensors is changing traditional microbial cell culture. By providing insights into cellular metabolism and localized environmental conditions, optical sensing of critical process parameters is proving useful for analysis, experimental design, and manufacturing control.
After 25 years with an extensive track record of success in the Medical Device space, Bucky Polk joined SBI in July 2020. He is a well-rounded executive with a vast collection of skills and experiences. Colleagues and customers have said that his authenticity, candor, and ability to connect with people are what set him apart. In his most recent role for Philips, he was responsible for the customer engagement of the most influential global Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists.
All-in-one Sensing System Poised to Unlock Bioprocessing “Black Box” PITTSBURGH, PA / ACCESSWIRE / February 16, 2021 / Scientific Bioprocessing, Inc. (SBI), a subsidiary of publicly-owned Scientific Industries, Inc. (OTCQB:SCND), announced today the launch of its Intelligent, Dynamic (ID) Fiber Optic Kit. The ID·Fiber Optic Kit is an all-in-one pH and dissolved oxygen sensing solution…
Ian is an industrial microbiologist and fermentation scientist specializing in process optimization and upstream modification of cell culture parameters for increased yield, viability, and productivity. Experienced with a variety of fermentation technologies, including hollow-fiber bioreactor systems, industrial stirred-tanks, and shake-flasks, Ian is excited to lend his background in cell culture to the SBI team.
UMBC-Scientific Bioprocessing, Inc. Collaboration Sparks Idea to Create More Hands-On Biotech Experience for Students
At the University of Maryland, Baltimore County (UMBC), Dr. Annica Wayman, Associate Dean for Shady Grove Affairs in the College of Natural and Mathematical Sciences, is seeking industry partners to support the launch of a new undergraduate degree program for UMBC students that would provide real-world, hands-on biotech experience.
Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical experience, focused primarily on oncology, infectious disease, and critical care/ICU medicine. He has overseen and managed the successful launch of over 16 new FDA approved products/compounds or new indications, and worked to gain formulary approval in managed care organizations, thereby improving access for patients.